Also, that an elevated C-reactive protein identifies those patients with T-lymphocyte impairment (Maccio et al, 1998; Canna et al, 2005) or patients with a proangiogenic environment (Kofler et al, 2005; Xavier et al, 2006) allowing unrestrained tumour growth and dissemination. Here, CRP is linked to neoplasm.